Metin UYSALOL, Fatih HAŞLAK, Zeynep Güneş ÖZÜNAL, Hayriye VEHİD, Nedret UZEL

Rational drug use for acute bronchiolitis in emergency care

Despite the large variety of inhaled treatment options of acute bronchiolitis,there is no generally agreed treatment regime. This study aimed to determinethe most appropriate treatment option. This was a double-blind randomizedprospective clinical trial and has been performed in emergency department. Themean age of the 378 infants included in the study was 7.63 ± 4.6 months,and 54.8% (207) were boys. Patients were randomized by using the lotterymethod for simple random sample into 5 different treatment options; 3%hypertonic saline, nebulized adrenaline, nebulized adrenaline mixed with 3%hypertonic saline, nebulized salbutamol, and as control group; normal saline(0.9% NaCl). From the first treatment time until discharge time; treatmentdurations, adverse events and readmission rates within the first fifteendays were recorded for each patient. Nebulized adrenaline mixed with 3%hypertonic saline, as compared with other options, were associated with asignificantly higher discharge rate at 4th hours (p

PDF

___

1. Simsek-Kiper PO, Kiper N, Hascelik G, et al. Emergency room management of acute bronchiolitis: a randomized trial of nebulized epinephrine. Turk J Pediatr 2011; 53: 651-660.

2. Leader S, Kohlhase K. Recent trends in severe respiratory syncytial virus (RSV) among US infants, 1997 to 2000. J Pediatr 2003; 143: 127-132.

3. Simoes EF. Environmental and demographic risk factors for respiratory syncytial virus lower respiratory tract disease. J Pediatr 2003; 143: 118-126.

4. Hall BC, Long CE, Schnabel KC. Respiratory syncytial virus infections in previously healthy working adults. Clin Infect Dis 2001; 33: 792-796.

5. Yorita KL, Holman RC, Sejvar JJ, Steiner CA, Schonberger LB. Infectious disease hospitalizations among infants in the United States. Pediatrics 2008; 121: 244-252.

6. Ralston SL, Lieberthal AS, Meissner HC, et al. Clinical practice guideline: the diagnosis, management, and prevention of bronchiolitis. Pediatrics 2014; 134: 1474- 1502.

7. Seiden JA, Scarfone RJ. Bronchiolitis: An evidencebased approach to management. Clin Pediatr Emerg Med 2009; 10: 75-81.

8. Kuyucu S, Unal S, Kuyucu N, Yilgor E. Additive effects of dexamethasone in nebulized salbutamol or L-epinephrine treated infants with acute bronchiolitis. Pediatr Int 2004; 46: 539-544.

9. Wright RB, Pomerantz WJ, Luria JW. New approaches to respiratory infections in children: bronchiolitis and croup. Emerg Med Clin North Am 2002; 20: 93-114.

10. Wainwright C, Altamirano L, Cheney M, et al. A multicenter, randomized, double-blind, controlled trial of nebulized epinephrine in infants with acute bronchiolitis. N Engl J Med 2003; 349: 27-35.

11. Mull CC, Scarfone RJ, Ferri LR, et al. A randomized trial of nebulized epinephrine vs albuterol in the emergency department treatment of bronchiolitis. Arch Pediatr Adolesc Med 2004; 158: 113-118.

12. Scarfone R. Controversies in the treatment of bronchiolitis. Curr Opin Pediatr 2005; 17:62-66.

13. Smyth RL, Openshaw PJ. Bronchiolitis. Lancet 2006; 368: 312–322.

14. Bush A, Thomson AH. Acute bronchiolitis. BMJ 2007; 335: 1037–1041.

15. Wang EE, Milner RA, Navas L, Maj H. Observer agreement for respiratory signs and oxymetry in infants hospitalized with lower respiratory infections. Am Rev Respir Dis 1992; 145: 106-109.

16. Tal G, Cesar K, Oron A, Houri S, Ballin A, Mandelber A. Hypertonic saline/epinephrine treatment in hospitalized infants with viral bronchiolitis reduces hospitalization stay: 2 years’ experience. Isr Med Assoc J 2006; 8: 169-173.

17. Grewal S, Ali S, McConnell DW, Vandermeer B, Klassen TP. A randomized trial of nebulized 3% hypertonic saline with epinephrine in the treatment of acute bronchiolitis in the emergency department. Arch Pediatr Adolesc Med 2009; 163: 1007-1012.

18. Modaressi MR, Asadian A, Faghihinia J, Arashpour M, Mousavinasab F. Comparison of epinephrine to salbutamol in acute bronchiolitis. Iran J Pediatr 2012; 22 : 241-244.

19. Sanchez I, De Koster J, Powell RE, Wolstein R, Chernick V. Effect of racemic epinephrine and salbutamol on clinical score and pulmonary mechanics in infants with bronchiolitis. J Pediatr 1993; 122: 145-151.

20. Ray MS, Singh V. Comparison of nebulized adrenaline versus salbutamol in wheeze associated respiratory tract infection in infants. Indian Pediatr 2002; 39: 12-22.

21. Chen YJ, Lee WL, Wang CM, Chou HH. Nebulized hypertonic saline treatment reduces both rate and duration of hospitalization for acute bronchiolitis in infants: an updated meta-analysis. Pediatrics & Neonatology 2014; 55: 431-438.

22. Flores-González JC, Matamala-Morillo MA, RodriguezCampoy P, et al. Epinephrine improves the efficacy of nebulized hypertonic saline in moderate bronchiolitis: a randomised clinical trial. PloS One 2015; 10: e0142847.

23. Miraglia MDG, Saitta F, Leonardi S, et al. Effectiveness of nebulized hypertonic saline and epinephrine in hospitalized infants with bronchiolitis. Int J Immunopathol Pharmacol 2012; 25: 485-491.

24. Anil AB, Anil M, Saglam AB, Cetin N, Bal A, Aksu N. High volume normal saline alone is as effective as nebulized salbutamol-normal saline, epinephrinenormal saline, and 3% saline in mild bronchiolitis. Pediatr Pulmonol 2010; 45: 41-47.

25. Mandelberg A, Tal G, Witzling M, et al. Nebulized 3% Hypertonic Saline Solution Treatment in Hospitalized Infants With Viral Bronchiolitis. Chest 2003; 123: 481-487.

26. Skjerven HO, Hunderi JO, Brügmann-Pieper SK, et al. Racemic adrenaline and inhalation strategies in acute bronchiolitis. N Engl J Med 2013; 368: 2286-2293.

27. Sala KA, Moore A, Desai S, Welch K, Bhandari S, Carroll CL. Factors associated with disease severity in children with bronchiolitis. J Asthma 2015; 52: 268-272.

28. Jacobs JD, Foster M, Wan J, Pershad J. 7% Hypertonic saline in acute bronchiolitis: a randomized controlled trial. Pediatrics 2014; 133: e8-e13.